If one person can afford expensive treatment but another cannot, is it okay to refuse care to the less affluent person?
If there is a slight chance that an expensive experimental drug will prolong a dying person’s life, should the insurance company or health organization pay for use of the drug?
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here